Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Farmers Insurance
Healthtrust
Merck
Cerilliant
Argus Health
Colorcon
Dow
McKesson
Baxter

Generated: August 17, 2017

DrugPatentWatch Database Preview

Ibuprofen - Generic Drug Details

« Back to Dashboard

What are the generic sources for ibuprofen and what is the scope of ibuprofen patent protection?

Ibuprofen
is the generic ingredient in forty-four branded drugs marketed by Amneal Pharms, J And J Consumer Inc, Ani Pharms Inc, Bayer, Pfizer, Moberg Pharma North, Taro, Vintage Pharms, Marksans Pharma, Watson Labs, Sandoz, Sun Pharm Inds, Superpharm, LNK, Dr Reddys Labs Inc, Granules India Ltd, Aiping Pharm Inc, Perrigo R And D, Ohm Labs, Mcneil, Actavis Mid Atlantic, L Perrigo Co, Mcneil Ped, Purepac Pharm, Halsey, Par Pharm, Lederle, Strides Pharma, Contract Pharmacal, Northstar Hlthcare, Wyeth Cons, Amneal Pharms Ny, Bristol Myers, Aurolife Pharma Llc, Perrigo, P And L Dev Llc, Ivax Sub Teva Pharms, Teva, Mcneil Consumer, Basf, Mylan Pharms Inc, Hi-tech Pharmacal, Cumberland Pharms, Abbott, Alra, Mylan, Tris Pharma Inc, Avema Pharma, Dr Reddys La, OHM, Leiner, Pliva, Humanwell Puracap, Bionpharma Inc, Granules India, Merro Pharm, Sofgen Pharms, Exela Pharma Science, Recordati Rare, Pfizer Cons Hlthcare, Barr Labs Inc, Actavis Elizabeth, Forest Labs, and Dr Reddys Labs Ltd, and is included in two hundred and three NDAs. There are thirteen patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Ibuprofen has thirty-nine patent family members in eleven countries.

There are sixty-four drug master file entries for ibuprofen. Two hundred and fifty-six suppliers are listed for this compound.

Summary for Generic Name: ibuprofen

Tradenames:44
Patents:13
Applicants:64
NDAs:203
Drug Master File Entries: see list64
Suppliers / Packagers: see list256
Bulk Api Vendors: see list123
Clinical Trials: see list508
Patent Applications: see list9,606
Therapeutic Class:Anti-inflammatory Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:ibuprofen at DailyMed

Pharmacology for Ingredient: ibuprofen

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms Inc
IBUPROFEN
ibuprofen
TABLET;ORAL071144-001Jan 20, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Perrigo
IBUPROFEN
ibuprofen
TABLET;ORAL075995-001Mar 14, 2002OTCNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs Ltd
IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE
ibuprofen; pseudoephedrine hydrochloride
TABLET;ORAL077628-001Aug 14, 2006OTCNoNo► Subscribe► Subscribe► Subscribe
Recordati Rare
NEOPROFEN
ibuprofen lysine
INJECTABLE;INTRAVENOUS021903-001Apr 13, 2006APRXYesYes► Subscribe► SubscribeY ► Subscribe
Marksans Pharma
IBUPROFEN
ibuprofen
TABLET;ORAL090796-003Dec 21, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: ibuprofen

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mcneil Ped
MOTRIN
ibuprofen
TABLET, CHEWABLE;ORAL020135-001Nov 16, 1994► Subscribe► Subscribe
J And J Consumer Inc
CHILDREN'S MOTRIN
ibuprofen
TABLET, CHEWABLE;ORAL020601-001Nov 15, 1996► Subscribe► Subscribe
Mcneil Ped
MOTRIN
ibuprofen
TABLET, CHEWABLE;ORAL020135-001Nov 16, 1994► Subscribe► Subscribe
Pfizer
CHILDREN'S ADVIL
ibuprofen
SUSPENSION;ORAL020589-001Jun 27, 1996► Subscribe► Subscribe
J And J Consumer Inc
CHILDREN'S MOTRIN
ibuprofen
SUSPENSION/DROPS;ORAL020603-001Jun 10, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: ibuprofen

Country Document Number Estimated Expiration
Canada2767971► Subscribe
Japan2012523377► Subscribe
World Intellectual Property Organization (WIPO)2010105129► Subscribe
Germany60034044► Subscribe
China102625656► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
AstraZeneca
UBS
US Department of Justice
Federal Trade Commission
Harvard Business School
McKinsey
Express Scripts
Chubb
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot